Mechanisms of hepatic methylmercury uptake
- 1 November 1995
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 46 (3) , 343-353
- https://doi.org/10.1080/15287399509532040
Abstract
The mechanism by which methylmercury is cleared from hepatic portal blood was examined in isolated rat livers perfused single‐pass with Krebs‐Henseleit buffer. [203Hg]Methylmercury (0.24–24 μM) was infused over a 30‐min interval, followed by a 30‐min washout, as a complex with the endogenous ligands L‐cysteine (CH3Hg‐L‐cys), glutathione (CH3Hg‐SG), and serum albumin (CH3Hg‐albumin), or as a complex with dithiothreitol (CH3Hg‐DTT), chloride (CH3HgCl), and the D‐enantiomer of cysteine (CH3Hg‐D‐cys). The sulfhydryl‐containing compounds were added at a 10‐fold molar excess. When administered as the albumin complex, only a small fraction of the [2O3Hg]methylmercury was cleared from perfusate (∼8%) and excreted into bile (0.7%). Hepatic uptake and biliary excretion of methylmercury was considerably higher for the other complexes: The percent of the dose recovered in liver tissue and bile was, respectively, CH3Hg‐albumin, 6.9 and 0.7; CH3Hg‐L‐cys, 15.7 and 2.3; CH3Hg‐D‐cys, 27.1 and 2.8; CH3Hg‐SC, 17.7 and 2.1; CH3HgCl, 66.5 and 3.2; and CH3Hg‐DTT, 70.1 and 19.8. For the dithiothreitol complex, hepatic extraction of methylmercury was nearly complete during single‐pass perfusion. A comparison of hepatic removal of increasing doses of CH3Hg‐L‐cys and CH3Hg‐D‐cys revealed little difference in uptake between these two enantiomers. Moreover, the fraction of methylmercury removed was similar when infused at concentrations of 0.24, 2.4, and 24 μM, indicating no saturability of uptake within this dose range. Methylmercury was not hepatotoxic at concentrations up to 24 μM if administered as a mercaptide; however, the chloride complex (CH3HgCl) produced cholestasis and an increase in perfusion pressure at a concentration of only 0.24 μM. These findings indicate that hepatic methylmercury uptake and toxicity are dependent on the chemical form in blood plasma. Uptake was faster when methylmercury was present as a cysteine or glutathione complex, as compared to the albumin complex; however, the lack of stereoselectivity indicates that the uptake process may be relatively unselective.Keywords
This publication has 15 references indexed in Scilit:
- Multiple Canalicular Transport Mechanisms for Glutathione S-ConjugatesPublished by Elsevier ,1995
- Mechanisms of Metal Transport Across Liver Cell Plasma MembranesDrug Metabolism Reviews, 1991
- Absorption of methylmercury compounds from rat intestineToxicology Letters, 1990
- Effect of sex hormones on the fate of methylmercury and on glutathione metabolism in miceBiochemical Pharmacology, 1987
- Preparation of CH3203HgCl of high specific activityThe International Journal of Applied Radiation and Isotopes, 1985
- Biliary secretion of glutathione and of glutathione-metal complexes*1Fundamental and Applied Toxicology, 1985
- Organ distribution and cellular uptake of methyl mercury in the rat as influenced by the intra- and extracellular glutathione concentrationBiochemical Pharmacology, 1982
- Effects of coadministered low-molecular-weight thiol compounds on short-term distribution of methyl mercury in the ratToxicology and Applied Pharmacology, 1982
- Effects of l- or d-cysteine coadministration on short-term distribution of inorganic mercury in the ratToxicology and Applied Pharmacology, 1979
- The Pharmacology of Mercury CompoundsAnnual Review of Pharmacology, 1972